Developer docs
API playgroundTry for free, no card

Search company profiles

Aqua Pharma

Full company profile

uuid000f8vp

Namestring
Aqua Pharma
Legal namestring
Aqua Pharma AS
Websiteurl
aqua-pharma.com
Company typeenum
Private
Founded yearint
2009
Descriptiontext

Aqua Pharma AS is a Norwegian aquaculture veterinary services company founded in 2009 and headquartered in Lillehammer, operating as the Aqua Pharma Group joint venture between Solvay (Belgian specialty chemicals leader) and Aquatiq (Norwegian food safety reference). The company provides products, equipment, and services for the prevention and control of disease in salmon and shrimp farming, with hydrogen peroxide (H2O2) bath treatments — marketed as Paramove® — at the core of the portfolio. Its proprietary dosing equipment suite (Types N, C, S, and W containers) supports tarpaulin and well-boat treatment methods, with over 30 dosing systems installed globally and operations across nine countries including Norway, Scotland, Chile, Canada, the USA, Australia, Belgium, Ecuador, and Indonesia.

The technical platform combines veterinary-grade H2O2 chemistry with purpose-built mechanical dosing and, following the 50% Pulcea stake (May 2020), emerging acoustic-assisted treatment technology under the BREEZE initiative. Aqua Pharma has expanded from salmon into shrimp via the SEATRU™ microbial-control service platform (launched June 2022 in partnership with KYTOS and eFishery), and has obtained regulatory and sustainability validations including veterinary medicine registration, the Solar Impulse Foundation's Efficient Solutions Label (2019), and Aquaculture Stewardship Council supporter status.

The business model is built on two revenue streams: product sales of H2O2-based veterinary medicines and hardware sales of dosing equipment systems, complemented by recurring technical services, inspections, and bespoke engineering. Pricing is quote-based, sold through a direct enterprise field-sales motion via regional managers, with manufacturing executed through the Aquatiq Hygiene Systems partnership in Norway and Scotland. The customer base is concentrated in salmon farming geographies, with project-level relationships including Scottish Sea Farms (BREEZE host) and eFishery (SEATRU Indonesia). The company employs approximately 50 people globally and does not disclose revenue.

Short descriptiontext

Aqua Pharma is a Norwegian aquaculture veterinary services provider, jointly owned by Solvay and Aquatiq, that sells hydrogen peroxide bath treatments (Paramove®) and proprietary dosing equipment for sea lice and disease control in salmon and shrimp farms across nine countries.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersLillehammer, Norway
HQ citystring
Lillehammer
HQ countrystring
Norway
HQ regionstring
Europe
Markets served

Serves global market

Offices10 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
aquaculture veterinary services, hydrogen peroxide treatment, sea lice control, dosing equipment systems, water conditioning solutions
Industry3 codes
PRIMARYAFAEAAAK
Aquaculture Health, Biosecurity & Veterinary Services
Agriculture & Food Production/Animal Production & Aquaculture/Aquaculture (Fish & Shellfish Farming)
SECONDARYAFAEANAE
Aquaculture & Fish Health Services
SECONDARYAFAEANAK
Veterinary Pharmacy, Vaccine & Biologics Services
NAICS code2 codes
  • Veterinary Services54194
  • Finfish Farming and Fish Hatcheries112511
SIC code1 code
  • Pharmaceutical Preparations2834
Product category
Aquaculture Veterinary Health Products and Equipment
Social media profiles2 records
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model2 records
1Hydrogen Peroxide Treatment Products
TypeOthers
Description

Sale of H2O2 based veterinary medicines for sea lice and disease treatment in salmon and shrimp farms. Products include Paramove and Food Grade H2O2 for shrimp applications.

aqua-pharma.com
2Dosing Equipment Sales and Servicing
TypeHardware Sales
Description

Design, manufacture, and sale of dosing equipment systems (Type N, C, S, W containers). Also provides regular inspections, treatment-related technical services, and bespoke engineering for maritime installations.

aqua-pharma.com
Marketing channels4 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels3 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components6 values
Personnel, Supply Chain, Operations, Technology or R&D, Marketing or Sales, Infrastructure
Pricing details1 tier
1Custom enterprise pricing
ModelOtherBilling cadenceMulti-year contract
Notes

Quote-based pricing through regional managers; no public pricing available

aqua-pharma.com
GTM typeB2B
B2B
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Core offering1 text field

Aqua Pharma develops, manufactures, and supplies hydrogen peroxide-based veterinary medicines (Paramove®) together with proprietary dosing equipment for bath treatments used in salmon and shrimp aquaculture. Its portfolio supports sea lice and ectoparasite control, Amoebic Gill Disease management, and water conditioning/oxygenation for shrimp ponds, complemented by technical dosing services and emerging platforms such as SEATRU™ and BREEZE.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 3 values shown
  • H2O2 concentrations in aquaculture treatment are 0.08% or 0.02% vs 3% for wound disinfection and 6% for dental applications
+2 more records
Product overview1 text field

Aqua Pharma is a veterinary services provider for aquaculture offering a unified portfolio of disease prevention and control products and equipment for salmon and shrimp farming. The core offering centers on Paramove® hydrogen peroxide bath treatments (available as tarpaulin or well boat applications) for sea lice and parasite control. Supporting the core treatment products is a family of four specialized dosing equipment systems (Types N, C, S, W containers) for precise H₂O₂ delivery, along with associated technical services. For shrimp farming, the company provides water conditioning and oxygenation solutions, underpinned by the SEATRU™ microbial control service platform. The company also has emerging technology in development through the BREEZE consortium, combining acoustic technology with hydrogen peroxide treatments.

Product and service8 records
1Paramove® Bath Treatment
CategoryAquaculture Veterinary Medicine
Description

Registered hydrogen peroxide veterinary medicine for rapid removal of sea lice and other ectoparasites in salmon farms; decomposes into water and oxygen with zero residue post-treatment. Sold to commercial salmon farming operators and applied via tarpaulin or well-boat delivery.

2Tarpaulin Treatment
CategoryAquaculture Treatment Service
Description

In-pen bath treatment service using Paramove® H2O2 within a contained tarpaulin, minimizing fish handling and stress for salmon farms.

3Well Boat Treatment
CategoryAquaculture Treatment Service
Description

Bath treatment service delivered via well boat equipped with closed dosing systems, delivering precise treatment volumes for salmon parasite control with high safety standards.

4Water Conditioning & Oxygenation (Shrimp)
CategoryAquaculture Water Treatment
Description

Eco-friendly Food Grade hydrogen peroxide water conditioning and preventative oxygenation products designed to maintain water quality and prevent health issues in shrimp ponds.

5SEATRU™ Service Platform
CategoryAquaculture Health Service Platform
Description

Service platform for shrimp farmers offering microbial control through precise dosing recommendations, combining sanitisers, oxygen aids, and bioremediation supported by KYTOS microbial fingerprinting technology.

6Dosing Equipment Systems (Types N, C, S, W)
CategoryAquaculture Dosing Equipment
Description

Proprietary dosing containers (Type N high-capacity, Type C semi-automated, Type S flagship, Type W well-boat specific) for accurate delivery of pharmaceutical-grade 50% hydrogen peroxide; over 30 dosing systems installed globally.

7Dosing Services
CategoryAquaculture Technical Services
Description

Technical services including regular inspections, treatment-related technical support, and bespoke engineering for maritime installations of dosing systems.

8BREEZE Anti-Sea Lice Treatment
CategoryEmerging Aquaculture Treatment Technology
Description

Anti-sea lice treatment concept combining hydrogen peroxide bath treatment with Pulcea's acoustic technology; EIT Food-funded initiative aimed at more effective, less stressful sea lice removal.

Scale indicator3 records

Each record includes

Type, Value, Description, Source

Partnership10 partners
1Scottish Sea Farms
Strategic tierMinorTypeStrategic or Co-development PartnerAnnounced on2022-10-01
Description

Host partner for BREEZE anti-sea lice treatment trials at their Shetland salmon farm. October 2022 trials validated environmental safety of sonic technology in open marine environment.

aqua-pharma.com
2KYTOS
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2022-06-01
Description

Microbial fingerprinting experts collaborating on SEATRU research project to develop shrimp health management platform using precise dosing recommendations.

aqua-pharma.com
3eFishery
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2022-06-01
Description

World's largest aquaculture tech start-up serving as local partner for SEATRU research project in Indonesia. The initiative kicked off July 2022 with a two-year research project.

aqua-pharma.com
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2021-01-01
Description

European consortium funding the BREEZE initiative (EITFood funded). BREEZE project selected for EIT Food 2021 Business Plan for Sustainable Aquaculture.

Strategic tierMinorTypeStrategic or Co-development PartnerAnnounced on2021-01-01
Description

BREEZE consortium partner contributing academic research expertise to the sustainable aquaculture initiative.

Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2020-05-01
Description

Aqua Pharma took 50% stake in Pulcea under a six-figure deal. Pulcea developed sound energy technology to improve efficiency of sea lice treatments. Acoustic power causes oxygen bubbles from H2O2 breakdown to oscillate, causing more damage to lice while being less stressful for fish.

Strategic tierFlagshipTypeStrategic or Co-development PartnerAnnounced on2019-09-01
Description

Joint venture between Solvay and Aquatiq created Aqua Pharma Group in September 2019. Solvay provides deep expertise in hydrogen peroxide technology (Paramove product) while Aqua Pharma offers state-of-the-art dosing equipment. The partnership aims to become a key aquaculture player offering sustainable solutions for sea lice control and Amoebic Gill Disease (AGD).

Strategic tierFlagshipTypeStrategic or Co-development PartnerAnnounced on2019-09-01
Description

Joint venture partner providing Norwegian food safety expertise. Aquatiq brings expertise in food hygiene and safety to the partnership, establishing Aqua Pharma's foundation in disease prevention and control systems for salmon farming.

Strategic tierCoreTypeImplementation/ SI/ Consulting Partner
Description

Manufacturing partner for final dosing equipment designs. Manufactures dosing equipment at facilities in Lillehammer, Norway and Oban, Scotland.

Strategic tierCoreTypeChannel Partner/ Reseller/ Distributor
Description

Norwegian partner providing bath treatment services. Aqua Pharma partnership with AQS covers treatment delivery in Norway.

Recent move9 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Peers3 records
TypeDirect peer
Description

Pharmaq, now part of Zoetis, is a leading animal health company specialising in aquaculture vaccines and pharmaceuticals for salmon and other farmed fish. Direct overlap with Aqua Pharma's veterinary medicine portfolio for salmon and shrimp disease control.

TypeDirect peer
Description

Benchmark Holdings operates in aquaculture genetics and animal health, providing specialist health products and breeding services for salmon and shrimp. Comparable as a vertically integrated aquaculture health specialist with proprietary IP.

3MSD Animal Health (Intervet)
TypeBroad incumbent
Description

MSD Animal Health, the veterinary division of Merck, offers a broad portfolio including aquaculture vaccines and pharmaceuticals. Competes with Aqua Pharma across the salmon and shrimp health categories as a much larger incumbent.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers3 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment3 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile3 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature4 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles6 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

Subsidiaries1 record

Each record includes

Name, Acquired on, Relationship type, Type, Business focus

Compliance3 records

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Aqua Pharma

Aquaculture Veterinary Health Products and Equipmentaqua-pharma.com

Aqua Pharma is a Norwegian aquaculture veterinary services provider, jointly owned by Solvay and Aquatiq, that sells hydrogen peroxide bath treatments (Paramove®) and proprietary dosing equipment for sea lice and disease control in salmon and shrimp farms across nine countries.

What Aqua Pharma does

Aqua Pharma AS is a Norwegian aquaculture veterinary services company founded in 2009 and headquartered in Lillehammer, operating as the Aqua Pharma Group joint venture between Solvay (Belgian specialty chemicals leader) and Aquatiq (Norwegian food safety reference). The company provides products, equipment, and services for the prevention and control of disease in salmon and shrimp farming, with hydrogen peroxide (H2O2) bath treatments — marketed as Paramove® — at the core of the portfolio. Its proprietary dosing equipment suite (Types N, C, S, and W containers) supports tarpaulin and well-boat treatment methods, with over 30 dosing systems installed globally and operations across nine countries including Norway, Scotland, Chile, Canada, the USA, Australia, Belgium, Ecuador, and Indonesia.

The technical platform combines veterinary-grade H2O2 chemistry with purpose-built mechanical dosing and, following the 50% Pulcea stake (May 2020), emerging acoustic-assisted treatment technology under the BREEZE initiative. Aqua Pharma has expanded from salmon into shrimp via the SEATRU™ microbial-control service platform (launched June 2022 in partnership with KYTOS and eFishery), and has obtained regulatory and sustainability validations including veterinary medicine registration, the Solar Impulse Foundation's Efficient Solutions Label (2019), and Aquaculture Stewardship Council supporter status.

The business model is built on two revenue streams: product sales of H2O2-based veterinary medicines and hardware sales of dosing equipment systems, complemented by recurring technical services, inspections, and bespoke engineering. Pricing is quote-based, sold through a direct enterprise field-sales motion via regional managers, with manufacturing executed through the Aquatiq Hygiene Systems partnership in Norway and Scotland. The customer base is concentrated in salmon farming geographies, with project-level relationships including Scottish Sea Farms (BREEZE host) and eFishery (SEATRU Indonesia). The company employs approximately 50 people globally and does not disclose revenue.

Aqua Pharma firmographics

Firmographics
Name
Aqua Pharma
Legal name
Aqua Pharma AS
Website
https://aqua-pharma.com
Company type
Private
Founded year
2009
Operating status
Operating
Headcount range
11–50 employees
Short description
Aqua Pharma is a Norwegian aquaculture veterinary services provider, jointly owned by Solvay and Aquatiq, that sells hydrogen peroxide bath treatments (Paramove®) and proprietary dosing equipment for sea lice and disease control in salmon and shrimp farms across nine countries.
Ownership category
akta.pro rank

Aqua Pharma industry classification

Industry
Product category
Aquaculture Veterinary Health Products and Equipment
NAICS
Veterinary Services (54194), Finfish Farming and Fish Hatcheries (112511)
SIC
Pharmaceutical Preparations (2834)
akta.pro industry
PRIMARYAFAEAAAK
Aquaculture Health, Biosecurity & Veterinary Services
Agriculture & Food Production/Animal Production & Aquaculture/Aquaculture (Fish & Shellfish Farming)
SECONDARYAFAEANAE
Aquaculture & Fish Health Services
SECONDARYAFAEANAK
Veterinary Pharmacy, Vaccine & Biologics Services

Keywords

  • Aquaculture veterinary services
  • Hydrogen peroxide treatment
  • Sea lice control
  • Dosing equipment systems
  • Water conditioning solutions

Where Aqua Pharma is headquartered

Location

Headquarters

HQ city
Lillehammer
HQ country
Norway
HQ region
Europe

Offices10 records

Markets served

Aqua Pharma business model

Business model
GTM type
B2B
Offering type
Hardware or Manufacturing
Cost components
Personnel, Supply Chain, Operations, Technology or R&D, Marketing or Sales, Infrastructure

Revenue model

  1. Hydrogen Peroxide Treatment Products: Sale of H2O2 based veterinary medicines for sea lice and disease treatment in salmon and shrimp farms. Products include Paramove and Food Grade H2O2 for shrimp applications.
  2. Dosing Equipment Sales and Servicing: Design, manufacture, and sale of dosing equipment systems (Type N, C, S, W containers). Also provides regular inspections, treatment-related technical services, and bespoke engineering for maritime installations.

Pricing tiers

ModelBillingPrice
OtherMulti-year contractCustom enterprise pricing

Go-to-market motion1 record

Distribution channels3 records

Marketing channels4 records

Aqua Pharma product offering

Product offering

Core offering

Aqua Pharma develops, manufactures, and supplies hydrogen peroxide-based veterinary medicines (Paramove®) together with proprietary dosing equipment for bath treatments used in salmon and shrimp aquaculture. Its portfolio supports sea lice and ectoparasite control, Amoebic Gill Disease management, and water conditioning/oxygenation for shrimp ponds, complemented by technical dosing services and emerging platforms such as SEATRU™ and BREEZE.

Product overview

Aqua Pharma is a veterinary services provider for aquaculture offering a unified portfolio of disease prevention and control products and equipment for salmon and shrimp farming. The core offering centers on Paramove® hydrogen peroxide bath treatments (available as tarpaulin or well boat applications) for sea lice and parasite control. Supporting the core treatment products is a family of four specialized dosing equipment systems (Types N, C, S, W containers) for precise H₂O₂ delivery, along with associated technical services. For shrimp farming, the company provides water conditioning and oxygenation solutions, underpinned by the SEATRU™ microbial control service platform. The company also has emerging technology in development through the BREEZE consortium, combining acoustic technology with hydrogen peroxide treatments.

Differentiator

Problem solved

Functional benefit

Products and services

  • Paramove® Bath Treatment Registered hydrogen peroxide veterinary medicine for rapid removal of sea lice and other ectoparasites in salmon farms; decomposes into water and oxygen with zero residue post-treatment. Sold to commercial salmon farming operators and applied via tarpaulin or well-boat delivery.
  • Tarpaulin Treatment In-pen bath treatment service using Paramove® H2O2 within a contained tarpaulin, minimizing fish handling and stress for salmon farms.
  • Well Boat Treatment Bath treatment service delivered via well boat equipped with closed dosing systems, delivering precise treatment volumes for salmon parasite control with high safety standards.
  • Water Conditioning & Oxygenation (Shrimp) Eco-friendly Food Grade hydrogen peroxide water conditioning and preventative oxygenation products designed to maintain water quality and prevent health issues in shrimp ponds.
  • SEATRU™ Service Platform Service platform for shrimp farmers offering microbial control through precise dosing recommendations, combining sanitisers, oxygen aids, and bioremediation supported by KYTOS microbial fingerprinting technology.
  • Dosing Equipment Systems (Types N, C, S, W) Proprietary dosing containers (Type N high-capacity, Type C semi-automated, Type S flagship, Type W well-boat specific) for accurate delivery of pharmaceutical-grade 50% hydrogen peroxide; over 30 dosing systems installed globally.
  • Dosing Services Technical services including regular inspections, treatment-related technical support, and bespoke engineering for maritime installations of dosing systems.
  • BREEZE Anti-Sea Lice Treatment Anti-sea lice treatment concept combining hydrogen peroxide bath treatment with Pulcea's acoustic technology; EIT Food-funded initiative aimed at more effective, less stressful sea lice removal.

Quantifiable outcome

  • H2O2 concentrations in aquaculture treatment are 0.08% or 0.02% vs 3% for wound disinfection and 6% for dental applications
  • +2 more outcomes

Companies that use Aqua Pharma

Customer profile

Named customers3 records

Segments3 records

Ideal customer profiles3 records

Aqua Pharma technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature4 records

Aqua Pharma partnerships and signals

Strategic signal

Partnerships

Ten partnerships are on record, tiered minor, core and flagship.

  • Scottish Sea FarmsminorStrategic or Co-development Partner · 1 October 2022Host partner for BREEZE anti-sea lice treatment trials at their Shetland salmon farm. October 2022 trials validated environmental safety of sonic technology in open marine environment.
  • KYTOScoreStrategic or Co-development Partner · 1 June 2022Microbial fingerprinting experts collaborating on SEATRU research project to develop shrimp health management platform using precise dosing recommendations.
  • eFisherycoreStrategic or Co-development Partner · 1 June 2022World's largest aquaculture tech start-up serving as local partner for SEATRU research project in Indonesia. The initiative kicked off July 2022 with a two-year research project.
  • EIT FoodcoreStrategic or Co-development Partner · 1 January 2021European consortium funding the BREEZE initiative (EITFood funded). BREEZE project selected for EIT Food 2021 Business Plan for Sustainable Aquaculture.
  • Norwegian University of Science & Technology (NTNU)minorStrategic or Co-development Partner · 1 January 2021BREEZE consortium partner contributing academic research expertise to the sustainable aquaculture initiative.
  • PulceacoreStrategic or Co-development Partner · 1 May 2020Aqua Pharma took 50% stake in Pulcea under a six-figure deal. Pulcea developed sound energy technology to improve efficiency of sea lice treatments. Acoustic power causes oxygen bubbles from H2O2 breakdown to oscillate, causing more damage to lice while being less stressful for fish.
  • SolvayflagshipStrategic or Co-development Partner · 1 September 2019Joint venture between Solvay and Aquatiq created Aqua Pharma Group in September 2019. Solvay provides deep expertise in hydrogen peroxide technology (Paramove product) while Aqua Pharma offers state-of-the-art dosing equipment. The partnership aims to become a key aquaculture player offering sustainable solutions for sea lice control and Amoebic Gill Disease (AGD).
  • AquatiqflagshipStrategic or Co-development Partner · 1 September 2019Joint venture partner providing Norwegian food safety expertise. Aquatiq brings expertise in food hygiene and safety to the partnership, establishing Aqua Pharma's foundation in disease prevention and control systems for salmon farming.
  • Aquatiq Hygiene SystemscoreImplementation/ SI/ Consulting PartnerManufacturing partner for final dosing equipment designs. Manufactures dosing equipment at facilities in Lillehammer, Norway and Oban, Scotland.
  • AQS (Aquaculture Quality Systems)coreChannel Partner/ Reseller/ DistributorNorwegian partner providing bath treatment services. Aqua Pharma partnership with AQS covers treatment delivery in Norway.

Scale indicators3 records

Recent moves9 records

Expansion highlights6 records

Aqua Pharma competitors and assessment

Company assessment

Direct peers

  • Pharmaq (Zoetis): Pharmaq, now part of Zoetis, is a leading animal health company specialising in aquaculture vaccines and pharmaceuticals for salmon and other farmed fish. Direct overlap with Aqua Pharma's veterinary medicine portfolio for salmon and shrimp disease control.
  • Benchmark Animal Health: Benchmark Holdings operates in aquaculture genetics and animal health, providing specialist health products and breeding services for salmon and shrimp. Comparable as a vertically integrated aquaculture health specialist with proprietary IP.

Broad incumbents

  • MSD Animal Health (Intervet): MSD Animal Health, the veterinary division of Merck, offers a broad portfolio including aquaculture vaccines and pharmaceuticals. Competes with Aqua Pharma across the salmon and shrimp health categories as a much larger incumbent.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights6 records

Customer concentration

Aqua Pharma social profiles

Digital presence

Aqua Pharma compliance and trust

Trust signal

Compliance3 records

Aqua Pharma financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Aqua Pharma leadership team

Management profile

Number of profiles

Profiles6 records

Aqua Pharma subsidiaries and ownership

Company hierarchy

Subsidiaries1 record

Aqua Pharma funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Aqua Pharma M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Aqua Pharma

What does Aqua Pharma do?

Aqua Pharma develops, manufactures, and supplies hydrogen peroxide-based veterinary medicines (Paramove®) together with proprietary dosing equipment for bath treatments used in salmon and shrimp aquaculture. Its portfolio supports sea lice and ectoparasite control, Amoebic Gill Disease management, and water conditioning/oxygenation for shrimp ponds, complemented by technical dosing services and emerging platforms such as SEATRU™ and BREEZE.

Is Aqua Pharma a public or private company?

Aqua Pharma is a private company. It is classified as corporate owned and is currently operating.

When was Aqua Pharma founded?

Aqua Pharma was founded in 2009. It employs 11 to 50 people.

Where is Aqua Pharma based?

Aqua Pharma is headquartered in Lillehammer, Norway, in the Europe region.

How does Aqua Pharma make money?

Two revenue lines are on record. Hydrogen Peroxide Treatment Products are the primary driver. The others are dosing Equipment Sales and Servicing.

Who are Aqua Pharma's main competitors?

Direct peers on record are Pharmaq (Zoetis) and Benchmark Animal Health. MSD Animal Health (Intervet) is listed as a broad incumbent.

Does Aqua Pharma have an API?

No public API is recorded for Aqua Pharma.

What industry is Aqua Pharma in?

Aqua Pharma's product category is Aquaculture Veterinary Health Products and Equipment. Its primary akta.pro industry code is AFAEAAAK, Aquaculture Health, Biosecurity & Veterinary Services, with a secondary code of AFAEANAE, Aquaculture & Fish Health Services. Its NAICS code is 54194 and its SIC code is 2834.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals